On February 24, 2021 Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, reported that management will participate in the following conferences in the month of March and invites investors to join by webcast (Press release, Oncternal Therapeutics, FEB 24, 2021, View Source [SID1234575559]). Please see details below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright: Global Life Sciences Conference (Virtual)
Title: Oncternal Therapeutics (ONCT) Company Presentation
Date: Tuesday, March 9th, 2021
Time: On demand, starting at 7:00 am Eastern Time
Presenter: James Breitmeyer, President & CEO
Webcasting Link: Here

Oppenheimer 31st Annual Healthcare Conference (Virtual)
Title: Oncternal Therapeutics (ONCT) Company Presentation
Date: Tuesday, March 16th, 2021
Time: 4:30 pm Eastern Time
Presenter: James Breitmeyer, President & CEO
Webcasting Link: Here
Webcasting Links:
Links to the webcasts along with replays will be accessible on the Events & Presentations page of the Investors section on the Company’s website at View Source